If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elena Santagostino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Hemophilia A Medicine & Life Sciences
Factor VIII Medicine & Life Sciences
Hemophilia B Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Immune Tolerance Medicine & Life Sciences
Safety Medicine & Life Sciences
Factor IX Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 8623 Citations
  • 53 h-Index
  • 252 Article
  • 8 Review article
  • 7 Letter
  • 3 Chapter
2 Citations (Scopus)

Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting

Kruse-Jarres, R., Oldenburg, J., Santagostino, E., Shima, M., Kempton, C. L., Kessler, C. M., Lehle, M., Chebon, S., Selak Bienz, N., Asikanius, E. & Mahlangu, J., Mar 1 2019, In : Haemophilia. 25, 2, p. 213-220 8 p.

Research output: Contribution to journalArticle

Hemophilia A
Hemorrhage
Safety
Factor VIII
Therapeutics

Consensus statements on vaccination in patients with haemophilia—results from the italian haemophilia and vaccinations (Heva) project

Santagostino, E., Riva, A., Cesaro, S., Esposito, S., Matino, D., Mazzucchelli, R. I., Molinari, A. C., Mura, R., Notarangelo, L. D., Tagliaferri, A., Di Minno, G. & Clerici, M., Jan 1 2019, In : Haemophilia.

Research output: Contribution to journalArticle

Hemophilia A
Vaccination
Factor VIII
Appointments and Schedules
Vaccines

Consensus statements on vaccination in patients with haemophilia—results from the italian haemophilia and vaccinations (Heva) project

HEVA Study Group, Santagostino, E., Riva, A., Cesaro, S., Esposito, S., Matino, D., Mazzucchelli, R. I., Molinari, A. C., Mura, R., Notarangelo, L. D., Tagliaferri, A., Di Minno, G. & Clerici, M., Jan 1 2019, In : Haemophilia. 25, 4, p. 656-667

Research output: Contribution to journalArticle

Open Access
Hemophilia A
Vaccination
Factor VIII
Appointments and Schedules
Vaccines
1 Citation (Scopus)

Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis

Samuelson Bannow, B., Recht, M., Négrier, C., Hermans, C., Berntorp, E., Eichler, H., Mancuso, M. E., Klamroth, R., O'Hara, J., Santagostino, E., Matsushita, T. & Kessler, C., May 1 2019, In : Blood Reviews. 35, p. 43-50 8 p.

Research output: Contribution to journalReview article

Open Access
Factor VIII
Hemophilia A
Hemostasis
Proteins
Factor IXa

Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A

Chowdary, P., Carcao, M., Holme, P. A., Jiménez-Yuste, V., Lentz, S. R., Møss, J., Poulsen, L. H., Shen, C., Tosetto, A., Wheeler, A. & Santagostino, E., Jul 2019, In : Research and practice in thrombosis and haemostasis. 3, 3, p. 542-554 13 p.

Research output: Contribution to journalArticle

Factor VIII
Hemophilia A
Half-Life
von Willebrand Factor
Pharmacokinetics